Participants will learn about the prevalence, incidence, and economic impact of venous thromboembolism and atrial fibrillation on patients, as well as the associated treatments and clinical data relating to efficacy, safety, and cost-efficacy.
Charles E. Mahan, PharmD, RPh, PhC
Advertisement
Articles by Charles E. Mahan, PharmD, RPh, PhC
Advertisement
Latest Updated Articles
- The Impact of Direct Oral Anticoagulants in the Managed Care Environment
Published: December 17th 2015 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Abemaciclib Plus Endocrine Therapy Improves Overall Survival in High-Risk Early Breast Cancer
2
Medicare State Rankings Reveal Stark Differences in Access, Quality, and Affordability
3
New Biomarkers, Drug Targets Identified for Colorectal Cancer
4
Real-World Data Show Preventive Nirsevimab Reduces Infant RSV Hospitalizations
5
